| Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children JV Williams, PA Harris, SJ Tollefson, LL Halburnt-Rush, JM Pingsterhaus, ... New England Journal of Medicine 350 (5), 443-450, 2004 | 1280 | 2004 |
| Potently neutralizing and protective human antibodies against SARS-CoV-2 SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ... Nature 584 (7821), 443-449, 2020 | 1203 | 2020 |
| Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition AJ Greaney, TN Starr, P Gilchuk, SJ Zost, E Binshtein, AN Loes, SK Hilton, ... Cell host & microbe 29 (1), 44-57. e9, 2021 | 1147 | 2021 |
| Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ... Nature medicine 27 (4), 717-726, 2021 | 969 | 2021 |
| Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors X Yu, T Tsibane, PA McGraw, FS House, CJ Keefer, MD Hicar, ... Nature 455 (7212), 532-536, 2008 | 811 | 2008 |
| An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies LA VanBlargan, JM Errico, PJ Halfmann, SJ Zost, JE Crowe Jr, LA Purcell, ... Nature medicine 28 (3), 490-495, 2022 | 779 | 2022 |
| Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 MC Woodruff, RP Ramonell, DC Nguyen, KS Cashman, AS Saini, ... Nature immunology 21 (12), 1506-1516, 2020 | 733 | 2020 |
| Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus R Xu, DC Ekiert, JC Krause, R Hai, JE Crowe Jr, IA Wilson Science 328 (5976), 357-360, 2010 | 705 | 2010 |
| Proof of principle for epitope-focused vaccine design BE Correia, JT Bates, RJ Loomis, G Baneyx, C Carrico, JG Jardine, ... Nature 507 (7491), 201-206, 2014 | 610 | 2014 |
| Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein SJ Zost, P Gilchuk, RE Chen, JB Case, JX Reidy, A Trivette, RS Nargi, ... Nature medicine 26 (9), 1422-1427, 2020 | 513 | 2020 |
| Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions R De Alwis, SA Smith, NP Olivarez, WB Messer, JP Huynh, ... Proceedings of the National Academy of Sciences 109 (19), 7439-7444, 2012 | 473 | 2012 |
| Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice G Sapparapu, E Fernandez, N Kose, B Cao, JM Fox, RG Bombardi, ... Nature 540 (7633), 443-447, 2016 | 427 | 2016 |
| Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein N Suryadevara, S Shrihari, P Gilchuk, LA VanBlargan, E Binshtein, ... Cell 184 (9), 2316-2331. e15, 2021 | 412 | 2021 |
| Mxra8 is a receptor for multiple arthritogenic alphaviruses R Zhang, AS Kim, JM Fox, S Nair, K Basore, WB Klimstra, R Rimkunas, ... Nature 557 (7706), 570-574, 2018 | 410 | 2018 |
| Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy PF Wright, RA Karron, RB Belshe, J Thompson, JE Crowe Jr, TG Boyce, ... The Journal of infectious diseases 182 (5), 1331-1342, 2000 | 386 | 2000 |
| 2013 A Smith, R de Alwis, N Kose, AP Durbin, SS Whitehead, AM de Silva, ... The theory of moral sentiments, 1759 | 378 | 1759 |
| Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection ES Winkler, P Gilchuk, J Yu, AL Bailey, RE Chen, Z Chong, SJ Zost, ... Cell 184 (7), 1804-1820. e16, 2021 | 361 | 2021 |
| Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape NI Mazur, J Terstappen, R Baral, A Bardají, P Beutels, UJ Buchholz, ... The Lancet Infectious Diseases 23 (1), e2-e21, 2023 | 322 | 2023 |
| High frequency of shared clonotypes in human B cell receptor repertoires C Soto, RG Bombardi, A Branchizio, N Kose, P Matta, AM Sevy, ... Nature 566 (7744), 398-402, 2019 | 321 | 2019 |
| The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience JV Williams, CK Wang, CF Yang, SJ Tollefson, FS House, JM Heck, ... The Journal of infectious diseases 193 (3), 387-395, 2006 | 314 | 2006 |
Pavlo GilchukAstraZenecaE-mail megerősítve itt: astrazeneca.com